Class III · Low risk Ongoing
Javygtor
Reason Failed Impurities/Degradation Specifications
FDA Drug Recalls
2,661 recalls, newest first
Class II · Moderate risk Ongoing
10 Irregular Pigmentation
Reason CGMP Deviations: Inconsistency in the water systems.
Class II · Moderate risk Ongoing
Levothyroxine Sodium Tablets
Reason Subpotent and Superpotent Drug
Class II · Moderate risk Ongoing
Levothyroxine Sodium Tablets
Reason Subpotent and Superpotent Drug
Class II · Moderate risk Ongoing
Levothyroxine Sodium Tablets
Reason Subpotent and Superpotent Drug
Class II · Moderate risk Ongoing
Levothyroxine Sodium Tablets
Reason Subpotent and Superpotent Drug
Class II · Moderate risk Ongoing
Levothyroxine Sodium Tablets
Reason Subpotent and Superpotent Drug
Class II · Moderate risk Ongoing
Levothyroxine Sodium Tablets
Reason Subpotent and Superpotent Drug
Class II · Moderate risk Ongoing
Duloxetine DR Capsules USP 60 mg
Reason CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended interim limit
Class II · Moderate risk Ongoing
Duloxetine Delayed-Release Capsules USP
Reason CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended interim limit
Class II · Moderate risk Ongoing
Duloxetine Delayed-Release Capsules USP
Reason CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended interim limit
Class I · High risk Ongoing
Clonazepam Orally Disintegrating Tablets
Reason Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength.
Class I · High risk Ongoing
Clonazepam Orally Disintegrating Tablets
Reason Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength.
Class I · High risk Ongoing
Clonazepam Orally Disintegrating Tablets
Reason Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength.
Class I · High risk Ongoing
Clonazepam Orally Disintegrating Tablet
Reason Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength.
Class II · Moderate risk Ongoing
Levothyroxine Sodium Tablets USP
Reason Superpotent Drug and Subpotent Drug: potency failures obtained
Class II · Moderate risk Ongoing
Levothyroxine Sodium Tablets USP
Reason Superpotent Drug and Subpotent Drug: potency failures obtained
Class II · Moderate risk Ongoing
Levothyroxine Sodium Tablets USP
Reason Superpotent Drug and Subpotent Drug: potency failures obtained
Class II · Moderate risk Ongoing
Levothyroxine Sodium Tablets USP
Reason Superpotent Drug and Subpotent Drug: potency failures obtained
Class II · Moderate risk Ongoing
Levothyroxine Sodium Tablets USP
Reason Superpotent Drug and Subpotent Drug: potency failures obtained
Class II · Moderate risk Ongoing
Levothyroxine Sodium Tablets USP
Reason Superpotent Drug and Subpotent Drug: potency failures obtained
Class II · Moderate risk Ongoing
Levothyroxine Sodium Tablets USP
Reason Superpotent Drug and Subpotent Drug: potency failures obtained
Class II · Moderate risk Ongoing
Levothyroxine Sodium Tablets USP
Reason Superpotent Drug and Subpotent Drug: potency failures obtained
Class II · Moderate risk Ongoing
Levothyroxine Sodium Tablets USP
Reason Superpotent Drug and Subpotent Drug: potency failures obtained
Class II · Moderate risk Ongoing
Levothyroxine Sodium Tablets USP
Reason Superpotent Drug and Subpotent Drug: potency failures obtained